NAN Chart, page-12

The NAN SP is reacting as it has done for the past few years. Sell off just before reportig.
Today there is news that a senior executive has left NAN to join EMV. Basically following Ron Weinberger.

"EMvision Medical Devices Limited (ASX: EMV) (“EMvision” or the “Company”) is pleased to announce
that it has strengthened its organisational capability with the appointment of medical device program
management expert, Forough Khandan, in the role of Head of Program Management for EMVision.
Forough was previously Program Manager at Nanosonics (ASX:NAN), reporting directly to the CTO, where
she led a large multi-disciplined team of engineers and scientists across the business.
During her 9-year tenure at Nanosonics, Forough successfully planned and executed highly complex new
product development programs and was key in leading activities required to define, develop and deliver
Nanosonics’ second generation of trophon device from prototype through to after-market release. Forough
was also responsible for specific strategic partnerships and engagement programs."

That is impressive. I presume she was involved in the new products. Is this a signal that these products are progessing well??? EMV would hardly employ a failure